2F9U | Viral Protein | date | Dec 06, 2005 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Hcv Ns3 Protease Domain With Ns4a Peptide And A Ketoamide In With A P2 Norborane | ||||||||||||||
authors | S.Venkatraman, F.G.Njoroge, W.Wu, V.Girijavallabhan, A.J.Prongay N.Butkiewicz, J.Pichardo | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Ns3 Proteasehelicase' Chain: A, C Fragment: Protease Domain (Residues : 1-181) Engineered: Yes |
Organism_scientific: Hepatitis C Virus Organism_taxid: 11103 Strain: H Strain Gene: Ns3 Protease Domain ( Residues 1027-1207 Of The Polyp Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Jm109(De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Ns3(181)His6pet22b | ||||||||||||||
Molecule: Polyprotein Chain: B, D Fragment: Residues: 21-39 Engineered: Yes |
Synthetic: Yes Other_details: Solid-Phase Peptide Synthesis Of The Ns4a Re 21-39 Peptide With N-Terminal Kk And C-Terminal Kk Extensio | ||||||||||||||
symmetry | Space Group: H 3 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.60 Å | ||||||||||||
ligand | 5NH, ZN BindingDB | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Novel inhibitors of hepatitis C NS3-NS4A serine protease derived from 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid., Venkatraman S, Njoroge FG, Wu W, Girijavallabhan V, Prongay AJ, Butkiewicz N, Pichardo J, Bioorg Med Chem Lett. 2006 Mar 15;16(6):1628-32. Epub 2006 Jan 18. PMID:16413182 |
Data retrieval |
View 2F9U in 3D |
Visual 3D analysis of 2F9U |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2F9U |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |